Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human NMDAR2A ELISA Kit (AC2596)
Cat.#: ASET-1185
Specifications
Description Human NMDAR2A ELISA Kit allows for the in vitro quantitative determination of human NMDAR2A concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.188 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.313-20 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1767 Human Neurokinin B Receptor ELISA Kit (AC3178) Quantitative inquiry ASET-1266 Mouse Cathepsin D ELISA Kit (AC2677) Quantitative inquiry ASET-2387 Human Dynamin 1 ELISA Kit (AC3798) Quantitative inquiry ASET-1425 Mouse Synaptophysin ELISA Kit (AC2836) Quantitative inquiry ASET-1569 Rat alpha MSH ELISA Kit (AC2980) Quantitative inquiry ASET-2295 Rat GABA ELISA Kit (AC3706) Quantitative inquiry ASET-2258 Human CBLN2 ELISA Kit (AC3669) Quantitative inquiry ASET-2386 Human SCN11A ELISA Kit (AC3797) Quantitative inquiry ASET-2182 Human Midkine ELISA Kit (AC3593) Quantitative inquiry ASET-1100 Human IL-6 ELISA Kit (AC2511) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket